Spruce Biosciences, Inc. · NASDAQ:SPRB
Ikarian Capital, LLC's stake in Spruce Biosciences, Inc. fell to 4.80% (Schedule 13G/A)
Event Apr 30, 2026 · Filed May 7, 2026
Ikarian Capital, LLC's stake in Spruce Biosciences, Inc. fell to 4.80%, 121,356 shares, as a passive investor on Apr 30, 2026. Filed May 7, 2026 (Schedule 13G/A).
- Stake
- 4.80%
- Shares
- 121,356
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 4.80% | 121,356 |
| Neil Shahrestani | 4.80% | 121,356 |
Source
Related
- Spruce Biosciences, Inc.
- Ikarian Capital, LLC
- Spruce Biosciences, Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · Nov 7, 2025
- Schedule 13G · Ikarian Capital, LLC · Oct 8, 2025
- Schedule 13G · AWM Investment Company, Inc. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Millennium Management LLC · Aug 4, 2026